Table 5.
Univariable and multivariable analysis of factors associated with survival in patients with HCC underwent TACE using Cox regression
| Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|
| Factors | HR | 95%CI | p-value | Factors | HR | 95%CI | p-value |
| Age | 0.99 | 0.97–1.007 | 0.26 | ||||
| Sex (male) | 1.24 | 0.99–1.56 | 0.07 | ||||
| MELD score | 1.07 | 0.98–1.16 | 0.14 | ||||
| Within up-to-seven criteria | 0.92 | 0.68–1.26 | 0.62 | ||||
| CTP B | 1.17 | 0.69–1.99 | 0.57 | ||||
| AFP > 20 ng/mL | 1.82 | 1.16–2.85 | 0.009* | AFP > 20 ng/mL | 1.77 | 1.10–2.84 | 0.018* |
|
Baseline EZ-ALBI Grade 1 Grade 2 Grade 3 |
– 1.36–3.52 1.14–6.40 |
– 0.001* 0.023* |
Baseline EZALBI Grade 1 Grade 2 Grade 3 |
- 1.24–3.88 1.24–8.57 |
- 0.007* 0.016* |
||
|
1 (ref) 2.19 2.71 |
1 (ref) 2.20 3.26 |
||||||
| Worsening EZ-ALBI grade | 0.94 | 0.60–1.46 | 0.77 | ||||
AFP Alpha fetoprotein, CI Confident interval, CTP Child-Turcotte-Pugh, EZ-ALBI Easy albumin-bilirubin, HR Hazard ratio, MELD Model for end-stage liver disease, ng/mL Nanogram per milliliter
*Significant p-value is ≤ 0.05